Your browser doesn't support javascript.
loading
Association of dry skin with intercellular lipid composition of stratum corneum after erlotinib administration.
Uchino, Tomonobu; Fujino, Hiyori; Kamiya, Daichi; Suzuki, Tomonori; Miyazaki, Yasunori; Asada, Kazuhiro; Shirai, Toshihiro; Yagi, Hiroaki; Sano, Yuko; Moriki, Mutsumi; Mizuno, Hajime; Todoroki, Kenichiro; Kimura, Midori; Kagawa, Yoshiyuki.
Afiliação
  • Uchino T; Laboratory of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, Japan. uchinot@u-shizhuoka-ken.ac.jp.
  • Fujino H; Laboratory of Clinical Pharmacokinetics, the Medical Frontier Center, Shizuoka General Hospital, 4-27-1 Kita Ando Aoi-ku, Shizuoka, Japan. uchinot@u-shizhuoka-ken.ac.jp.
  • Kamiya D; Laboratory of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, Japan.
  • Suzuki T; Laboratory of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, Japan.
  • Miyazaki Y; Laboratory of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, Japan.
  • Asada K; Laboratory of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, Japan.
  • Shirai T; Laboratory of Clinical Pharmacokinetics, the Medical Frontier Center, Shizuoka General Hospital, 4-27-1 Kita Ando Aoi-ku, Shizuoka, Japan.
  • Yagi H; Department of Respiratory Medicine, Shizuoka General Hospital, 4-27-1 Kita Ando Aoi-ku, Shizuoka, Japan.
  • Sano Y; Department of Respiratory Medicine, Shizuoka General Hospital, 4-27-1 Kita Ando Aoi-ku, Shizuoka, Japan.
  • Moriki M; Department of Dermatology, Shizuoka General Hospital, 4-27-1 Kita Ando Aoi-ku, Shizuoka, Japan.
  • Mizuno H; Department of Dermatology, Shizuoka General Hospital, 4-27-1 Kita Ando Aoi-ku, Shizuoka, Japan.
  • Todoroki K; Department of Dermatology, Shizuoka General Hospital, 4-27-1 Kita Ando Aoi-ku, Shizuoka, Japan.
  • Kimura M; Laboratory of Analytical and Bio-Analytical Chemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, Japan.
  • Kagawa Y; Laboratory of Analytical and Bio-Analytical Chemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, Japan.
Cancer Chemother Pharmacol ; 86(2): 233-243, 2020 08.
Article em En | MEDLINE | ID: mdl-32666159
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anormalidades da Pele / Carcinoma Pulmonar de Células não Pequenas / Cloridrato de Erlotinib / Lipídeos / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anormalidades da Pele / Carcinoma Pulmonar de Células não Pequenas / Cloridrato de Erlotinib / Lipídeos / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão